New sudan ebola vaccine shows promise in phase 2 trial
NCT ID NCT06036602
First seen Apr 02, 2026 · Last updated May 20, 2026 · Updated 3 times
Summary
This study tested a new vaccine designed to protect against Sudan ebolavirus, a deadly virus similar to Ebola. Researchers gave the vaccine or a placebo to 125 healthy adults to check if it is safe and triggers a strong immune response. The goal is to find a way to prevent this serious disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBOLA SUDAN VIRUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
KEMRI/Centre for Respiratory Disease Research Siaya Clinical Research Annex
Siaya, Kenya
-
Makerere University-Walter Reed Project
Kampala, Uganda
Conditions
Explore the condition pages connected to this study.